2 Matching Annotations
  1. Last 7 days
    1. Screening of 92 unrelated patients with VHL disease revealed 61 DNA variants. No variants were found in 96 control cases. Peripheral blood samples were obtained and pre-screened for VHL mutations by undergoing denaturing gradient gel electrophoresis. All electrophoretic variants in exon 2 or 3 were sequenced from PCR amplified products, after purification on Microcon 100(Millipore, St. Quentin, France) filter units, using Prism ready reaction dye primer cycle sequencing kits (Applied Biosystem Roissy CDG France) and an ABI 373A automated sequencer (AppliedBiosystem Roissy CDG France). Direct sequencing was systematically performed on exon 1 PCR products. Southern blotting was used to search for larger alterations to the gene. This missense mutation, p.F91L(c.273C>G) was found in the germline of a male VHL patient (patient no. S3940) with apparently sporadic cerebellar hemangioblastoma diagnosed at age 56.

    2. PatientID: S3940

      KindredID: S3940

      Case: M, 56Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006880 (cerebellar hemangioblastoma)

      CaseHPOFreeText: Cerebellar hemangioblastoma was diagnosed at age 56.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.F91L(c.273C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351750747

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: F91L(c.273C>G)

      MultipleGeneVariants: N/A